Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Novel Recombination Human Nerve Growth Factor in Healthy Chinese Subjects.
Qi ShenMengyu ZhangYing JinXiangjie DiRunhan LiuZhenlei WangPublished in: CNS drugs (2023)
This study was registered with Chinadrugtrials.org.cn (ChiCTR2100042094) on January 13th, 2021.